COVID-19：エジプトで「アビガン」の臨床試験：4月１７日開始５０人に投与（動画)：
COVID-19: Clinical trial of “Avigan” in Egypt: starting April 17, administered to 50 people：
COVID-19：埃及“ Abigan”的临床试验：从4月17日开始，适用于50人
COVID-19：
新型コロナウイルスの感染者に対する「アビガン」の臨床試験が、エジプトで始まりました。
エジプトの地元紙：Egypt Today
新型インフルエンザ治療薬「アビガン」を使った臨床試験を、１７日開始し、すでに５０人に投与したと発表しました。
患者は複数の施設に入院しているとのこと。
エジプト政府：
政府は今後の経過を見ることで「アビガン」が新型コロナウイルスに効果があるか、見定めたいとしています。
エジプトでは、これまでに２８４４人の感染と２０５人の死者が発表されています。
https://news.tbs.co.jp/sp/newseye/tbs_newseye3958846.html
Egypt to test Japanese anti-viral drug Avigan in clinical trials
CAIRO – 12 April 2020:
Egypt is getting ready to conduct clinical trials on samples of the Japanese anti-viral drug Aviral as a treatment for COVID-19,
Advisor to the Minister of Higher Education for International Relations and Agreements for Scientific Research Affairs, Dr. Mohamed Al-Shennawy, said on Sunday.
On Friday, Minister of Higher Education and Scientific Research Khaled Abdel Ghaffar
said the ministry has managed to communicate with the Japanese manufacturer of the antiviral drug Avigan to treat patients with coronavirus (COVID-19).
The drug, developed by a group firm of Fujifilm Holdings Corp., has been stored in Japan as a treatment for influenza.
Reports in China showed that the drug has been effective in treating COVID-19, the respiratory disease caused by the virus.
Fujifilm Holdings Corp said on Thursday it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States, according to the NY Times.
The minister further added that Egypt is joining scientific research with Japan in an attempt to reach a medicine for the novel pandemic.
On March 31, Fujifilm announced the start of a phase III clinical trial of Avigan for COVID-19 patients in Japan.
Egypt Today
https://www.egypttoday.com/Article/1/84595/Egypt-to-test-Japanese-anti-viral-drug-Avigan-in-clinical